Indications and uses
Indication and usage 1. Always close the lid after use.2. Keep this product in the room temperature.
Indication and usage 1. Always close the lid after use.2. Keep this product in the room temperature.
Dosage and administration Apply suitable amount of powder evenly with a sponge on your face.
Active ingredients: Titanium Dioxide 7.188%
Inactive ingredients: Talc, Mica (CI 77019), Methyl Methacrylate Crosspolymer, Nylon-12, Silica, Ethylhexyl Methoxycinnamate, Trimethylolpropane Triethylhexanoate, HDI/Trimethylol Hexyllactone Crosspolymer, Barium Sulfate, Zinc Oxide (CI 77947), Ethylene/Acrylic Acid Copolymer, Diisostearyl Malate, Magnesium Myristate, Caprylic/Capric Triglyceride, Methicone, Iron Oxides (CI 77492), Dimethicone, Ethylhexylglycerin, Triethoxycaprylylsilane, Glyceryl Caprylate, Iron Oxides (CI 77491), Iron Oxides (CI 77499), Ultramarines (CI 77007), Hydroxyapatite, Argania Spinosa Kernel Oil, Hippophae Rhamnoides Fruit Extract, Butylene Glycol
Purpose: Sunscreen
Warnings Keep out of eyes. Stop use if irritation occurs. Keep out of reach of babies and children.
Keep out of reach of babies and children.
Indication and usage 1. Always close the lid after use.2. Keep this product in the room temperature.
Dosage and administration Apply suitable amount of powder evenly with a sponge on your face.
| Resource | Code type | Value | Equivalent identifiers | Source image |
|---|---|---|---|---|
| Barcode | EAN-13 | 8809348113203 | GTIN-13: 8809348113203 EAN-13: 8809348113203 GTIN storage (14 digits): 08809348113203 | 3 concept eyes slim fit pact soft beige carton.jpg |
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 60764-010-01 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-b01a-f424-e053-dadaa90a57ce | 5a07cfb1-1b95-4604-9cd6-0934113f42f3 |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 60764-010-01 | 3 CONCEPT EYES SLIM FIT PACT SOFT BEIGE | 8 g in 1 CARTON | POWDER | 8 | 1 |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Titanium Dioxide | ACTIVE INGREDIENT | 15FIX9V2JP | 1 | |
| TITANIUM DIOXIDE | ACTIVE MOIETY | 15FIX9V2JP | 1 | |
| Mica | INACTIVE INGREDIENT | V8A1AW0880 | 1 | |
| Talc | INACTIVE INGREDIENT | 7SEV7J4R1U | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 60764-010 | 60764-010-01 |
Every source-derived ingredient row is available through these pages.
| Name | UNII | Kind |
|---|---|---|
| Titanium Dioxide | 15FIX9V2JP | ACTIB |
| Talc | 7SEV7J4R1U | IACT |
| Mica | V8A1AW0880 | IACT |
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Talc | TALC | 7SEV7J4R1U | CAPSULE / ORAL | 729 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL | 357 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / SUBLINGUAL | 32.4 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, ORALLY DISINTEGRATING / ORAL | 80 mg | ||
| Talc | TALC | 7SEV7J4R1U | POWDER, FOR SUSPENSION / ORAL | 735 mg | ||
| Talc | TALC | 7SEV7J4R1U | LOZENGE / ORAL | 50 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FOR SUSPENSION / ORAL | 24 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE / ORAL | 202 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / BUCCAL | 15 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED, EXTENDED RELEASE / ORAL | 60 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, FOR SUSPENSION / ORAL | 296 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE, DELAYED RELEASE / ORAL | 525 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, CHEWABLE, EXTENDED RELEASE / ORAL | 18 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, EXTENDED RELEASE / ORAL | 5119 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED, EXTENDED RELEASE / ORAL | 20 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE / ORAL | 349 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, DELAYED RELEASE PARTICLES / ORAL | 56 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED / ORAL | 87 mg | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, DELAYED RELEASE / ORAL | 420 mg | ||
| Talc | TALC | 7SEV7J4R1U | PELLET / ORAL | 69 mg | ||
| Talc | TALC | 7SEV7J4R1U | SUSPENSION, EXTENDED RELEASE / ORAL | 46 mg | ||
| Talc | TALC | 7SEV7J4R1U | POWDER / TOPICAL | 9235 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / ORAL | 1000 mg | ||
| Talc | TALC | 7SEV7J4R1U | DROPS / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | CAPSULE, COATED PELLETS / ORAL | 14 mg | ||
| Talc | TALC | 7SEV7J4R1U | SUSPENSION / ORAL | 234 mg | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, EXTENDED RELEASE / ORAL | 300 mg | ||
| Talc | TALC | 7SEV7J4R1U | ELIXIR / ORAL | 4.5 mg/5ml | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, FILM COATED / ORAL | 91 mg | ||
| Talc | TALC | 7SEV7J4R1U | GRANULE / ORAL | 322 mg | ||
| Talc | TALC | 7SEV7J4R1U | GUM, CHEWING / BUCCAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | TABLET / RECTAL | 32.4 mg | ||
| Talc | TALC | 7SEV7J4R1U | OINTMENT / TOPICAL | 74.6 %w/w | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, SUGAR COATED / ORAL | NA | ||
| Talc | TALC | 7SEV7J4R1U | TABLET, COATED / ORAL | 320.75 mg |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| 21cc3ea3-e3b3-4333-96e1-aa7b64c8a4c1 | 5a07cfb1-1b95-4604-9cd6-0934113f42f3 | 2013-10-03 | Warnings | 21cc3ea3-e3b3-4333-96e1-aa7b64c8a4c1 5a07cfb1-1b95-4604-9cd6-0934113f42f3 |
Adverse event summaries are temporarily unavailable. Other product information remains available.